<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>BioToday.com [新着ニュース]</title>
	<description>BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。</description>
	<link>http://www.biotoday.com/news.cfm</link>
	<managingEditor>biotoday@biotoday.com</managingEditor>
	<copyright>Copyright &#169; 2026 BioToday Ltd. All Rights Reserved.</copyright>
	<lastBuildDate>Sun, 19 Jul 2026 16:46:24 +0900</lastBuildDate>
	<language>ja</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title>[医学] 重症肺炎HIV乳児の死亡がバルガンシクロビル治療で減るかもしれない</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110289&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110289&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 19 Jul 2026 16:46:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110289&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 心房細動患者PCI後の抗凝固薬と抗血小板薬の併用1か月が12か月に劣らず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110288&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110288&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 19 Jul 2026 16:09:01 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110288&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 薬剤溶出ステント留置多枝冠動脈疾患患者への2年間の抗血小板薬2種併用が有益</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110287&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110287&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 19 Jul 2026 14:07:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110287&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 骨髄腫の先制治療後の2年を超えるlenalidomide引き継ぎ投与の生存改善示せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110286&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110286&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 19 Jul 2026 12:06:14 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110286&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Ph2試験の手筈が整っている急性腎障害薬をMission社がDimerix社に譲る</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110285&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110285&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 19 Jul 2026 10:56:05 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110285&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] IgA腎症へのNovartisの補体B因子阻害薬Fabhalta使用を米国が本承認した</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110284&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110284&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 19 Jul 2026 10:27:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110284&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Latigo社の非オピオイド鎮痛薬が腹の美容手術のPh2試験でプラセボを凌いだ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110283&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110283&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 18 Jul 2026 15:27:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110283&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 難治性慢性咳へのGSKのP2X3遮断薬camlipixant開発がPh3試験成績不出来で中止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110282&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110282&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 18 Jul 2026 12:02:21 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110282&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] CEPI推しオックスフォード大学のエボラウイルスワクチンがPh1試験入り</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110281&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110281&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 18 Jul 2026 11:15:09 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110281&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] J&amp;Jが地図状萎縮（GA）遺伝子治療JNJ-1887の開発中止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110280&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110280&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 中止</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 18 Jul 2026 10:24:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110280&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] LDLコレステロールを減らすMerck &amp; Coの経口PCSK9阻害薬Lipfendraを米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110279&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110279&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 18 Jul 2026 09:51:55 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110279&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] InnoCareのTYK2阻害薬soficitinibの白斑相手のPh2/3試験がPh3段階に進む</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110278&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110278&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 18 Jul 2026 09:39:44 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110278&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 自己抗原特異的Tregがオリゴデンドロサイトを増やしてミエリン再形成も促す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110277&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110277&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 18 Jul 2026 08:47:36 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110277&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] L-ドーパのパーキンソン病治療効果を促してジスキネジアは減らす化合物を同定</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110276&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110276&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 17 Jul 2026 16:01:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110276&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] LillyがAtaiBeckley社を買ってサイケデリック薬分野に手を出す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110275&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110275&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 17 Jul 2026 13:50:03 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110275&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 老化した好中球をマクロファージが排除するのを促すことで老化臓器が若返り</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110274&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110274&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 17 Jul 2026 11:37:27 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110274&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ニコチン入り小袋（nicotine pouch、ニコチンパウチ）で歯肉が後退するらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110273&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110273&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 16:37:45 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110273&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] EBVの複製で生じる蛋白質抗原へのCD4 T細胞反応が多発性硬化症では優勢</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110272&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110272&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 15:45:45 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110272&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] PTEN (phosphatase and TENsin homolog) が静脈性下肢潰瘍を治らなくしている</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110271&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110271&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 14:49:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110271&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脱共役薬CRMPがマウス動脈硬化を抑制</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110270&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110270&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 14:05:02 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110270&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 長らくの鉄過剰が抗酸化防御を損なわせて神経を死にやすくする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110269&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110269&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 12:18:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110269&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Insilico Medicineの人工知能（AI）技術提携に開発製造請負のBora社が加わる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110268&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110268&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 10:47:45 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110268&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Kelun-BiotechのMerckとの提携ADCがPD-L1陰性肺癌初治療Ph3試験でも目標達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110267&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110267&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 10:00:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110267&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 原発性胆汁性胆管炎（PBC）患者の9割近くがIpsenのIqirvoでALP値正常化</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110265&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110265&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 08:38:54 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110265&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] もとには戻らないとされていたタンパク質の老化反応を解消する酵素ができた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110266&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110266&amp;ref=rss</guid>
		<category>開発 / 前臨床試験 / 全般</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 16 Jul 2026 07:46:37 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110266&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Draig社がPh2試験段階の大うつ病薬DT-101の開発資金6500万ドル調達</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110264&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110264&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 15 Jul 2026 16:25:24 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110264&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Innovent社から中国外権利を手に入れたIgG4-RD薬Ph2試験をSpero社が来年開始</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110263&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110263&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 15 Jul 2026 15:57:10 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110263&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 抗IL-23薬の乾癬Ph2b試験を始めるAvere社がNextCure社合併を踏み台にして上場</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110262&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110262&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス || ビジネス / ファイナンス / 投資/融資 || ビジネス / 会社運営 / 開業</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 15 Jul 2026 12:19:39 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110262&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AstraZenecaが中国Dizal社の肺癌薬Zegfrovyの全世界権利を取得</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110261&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110261&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 15 Jul 2026 11:29:46 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110261&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Biogenのアルツハイマー病薬diranersenの低用量が頑張ったPh2試験結果詳細</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110260&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110260&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 15 Jul 2026 10:41:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110260&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 乳癌を治療するCelcuity社の汎PI3K/mTOR阻害薬Revtorpykを米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110259&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110259&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 15 Jul 2026 09:58:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110259&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] ヒトの血液細胞起源のiPS細胞から未成熟な精子を作れた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110258&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110258&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 15 Jul 2026 09:34:02 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110258&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Agenusが大腸癌Ph3試験を最初の患者組み入れから4か月と経たずに廃止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110257&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110257&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 15 Jul 2026 08:09:53 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110257&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 母親の体重などの特徴で補正した胎児成長曲線がより正確な目安となりうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110256&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110256&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 16:26:10 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110256&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 肥満薬はどれも取るに足る生きやすさの改善をもたらさず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110255&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110255&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 15:49:57 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110255&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 文化や習慣に合わせた生活習慣の指導と支援で認知機能がより改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110254&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110254&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 13:35:33 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110254&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 先立つ治療を経ているCLL/SLL患者の悪化/死亡率がLillyのJaypircaで45%低下</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110253&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110253&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 12:50:57 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110253&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] temocillinが第3世代セファロスポリン抵抗性腸内細菌目細菌の菌血症に有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110252&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110252&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 12:30:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110252&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ECMO患者の低強度抗凝固で出血事態を減らせそう</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110251&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110251&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 11:41:30 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110251&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 認知症を生じ難くするゲームがアルツハイマー病の病変除去を男性に限って促す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110250&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110250&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 10:19:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110250&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] GSKの抗PD-1抗体Jemperliが直腸癌相手の大一番試験で奏効目標達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110249&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110249&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 08:52:54 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110249&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Chai Discoveryの人工知能（AI）手段を利用した抗体探しにNovartisが取り組む</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110248&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110248&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 08:19:44 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110248&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] China Medical SystemがInsilico Medicineと組んで神経疾患治療の狙い目を探す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110247&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110247&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 07:54:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110247&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Q32 Bio社の抗IL-7Rα抗体bempikibartが重度円形脱毛症患者3人に1人ほどに奏効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110246&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110246&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 14 Jul 2026 07:15:31 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110246&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 髄膜炎ワクチンの淋病予防効果なし</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110245&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110245&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 13 Jul 2026 16:41:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110245&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] NSCLC切除患者に中国Betta社のALK阻害薬ensartinibが効いたPh3試験論文報告</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110244&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110244&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 13 Jul 2026 16:17:17 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110244&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 視床下部損傷患者の肥満にRhythm社のMC4R活性化薬が効いたPh3試験論文報告</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110243&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110243&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 13 Jul 2026 15:17:17 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110243&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 膝/股関節置換後の初っ端からのアスピリンがrivaroxaban前座投与に劣らず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110242&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110242&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 13 Jul 2026 14:46:25 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110242&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 卵巣を柔らかくする薬で生殖可能年齢を延ばせるかもしれない</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110241&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110241&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 13 Jul 2026 10:12:51 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110241&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 年嵩の卵子によくある染色体異常をシュゴシン1のmRNAの注入で減らしうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110240&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110240&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 11 Jul 2026 16:51:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110240&amp;ref=rss</comments>
	</item>
</channel>
</rss>
